Stephen Carter has resigned as managing director and chief executive of SUDA Pharmaceuticals after nearly 9 years with the company. Non-executive chair Paul Hopper will become interim executive chair until a permanent chief executive has been appointed.
24/09/2019 - 16:34
Board Moves September 24, 2019
Related Data & Insights
Nusantara ResourcesClosing price for the last 90 trading daysPowered by Morningstar ®